Related Experiment Video
Updated: Apr 21, 2026
09:42
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
Published on: January 2, 2017
39.4K
Summary
Efficient generation and maintenance of hybridomas are crucial for monoclonal antibody therapies. However, significant knowledge gaps hinder the stability and viability of these antibody-producing cell lines.
Area of Science:
- Biotechnology
- Immunology
- Cell Biology
Background:
- Monoclonal antibodies (mAbs) are vital therapeutics, but their production relies on hybridoma technology.
- Hybridoma cell lines are essential for consistent and large-scale mAb generation.
- Current challenges exist in maintaining the long-term stability and viability of these critical cell lines.
Purpose of the Study:
- To identify knowledge gaps in hybridoma stability and viability.
- To highlight areas for research to improve antibody-producing cell line maintenance.
- To facilitate the therapeutic potential of monoclonal antibodies through better hybridoma management.
Main Methods:
- Workshop discussions on hybridoma stability and viability.
- Expert consensus on current challenges and future research directions.
- Review of best practices in cell line maintenance.
Main Results:
- Significant knowledge gaps persist regarding hybridoma stability.
- Understanding the factors affecting hybridoma viability requires further investigation.
- Current methodologies may not fully ensure long-term cell line performance.
Conclusions:
- Addressing knowledge gaps in hybridoma stability and viability is critical for advancing therapeutic antibody development.
- Further research is needed to optimize the maintenance of antibody-producing cell lines.
- Improved hybridoma management will enhance the realization of mAb therapeutic potential.
Related Concept Videos
01:31Hybridoma Technology
13.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.0K
01:24B Cell Activation and Differentiation
14.1K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.1K
02:29Hybrid Zones
16.2K
Hybrid zones are narrow regions where two closely related species interact, mate, and produce hybrids. Relative to either parent species, hybrids may possess distinct phenotypic or genetic differences that impact their survival and reproductive success. The genetic variances introduced by hybridization influence species diversity and speciation processes within the hybrid zone.
16.2K